...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
AGORACOM NEWS FLASH

Dear Agoracom Family,

I want to thank all of you for your patience with us over the past 48 hours and apologize for what was admittedly a botched launch of our new site.

As you can see, we have reverted back to the previous version of the site while we address multiple forum functionality flaws that inexplicably made their way into the launch.

To this end:

1.We have identified 8 fundamental but easily fixable flaws that will be corrected in the coming week, so that you can continue to use the forums exactly as you've been accustomed to.

2.Additionally we will also be implementing a couple of design improvements to "tighten up" the look and feel of the forums.

Sincerely,

George et al

Message: Pfizer seems like a good fit for a BP deal

Realistically, maybe a few of us on here are "big fish" but not me. I have significant shares, at least for me, but certainly not on anybody's radar. But that doesn't mean that I don't have the same rights to responsible fiduciary activities, as Ori, Hepa, or Ken Dart.

So, really, I am just a "RVX big fish" (i.e. Ken Dart) coat tail rider, now at this point. And not much else. I just want what Dart gets, for his common shares, when it is all said and done.

And if I don't get fair treatment, then I am happy to join a class-action for a granular look under the hood. But for now I am on the back of Ken Dart's waverunner with him yippee ki yay!

Share
New Message
Please login to post a reply